Our results showed that RSL-induced ferroptosis may promote the antitumor efficiency of anti-PD-1 treatment by enhancing the repertoire and frequency of tumor neoantigen-specific IFN-γ+ CD8+ T cells. The gene discussed is PDCD1; the disease is neoplasm.